MedTech News
.................... by Andrew Celentano
Simple blood test could catch Alzheimer’s and Parkinson’s early by spotting misfolded proteins
A research team led by Professor Klaus Gerwert from Ruhr University Bochum, Germany, has developed just such a blood test. It is based on the immuno-infrared sensor, a novel platform technology to which the Journal of Physical Chemistry B dedicates its cover story in its issue from April 24, 2026.
Healium Announces FDA Registration of Healium Clinical as a Class II 510(k)-Exempt Biofeedback Medical Device
FDA Registration Accelerates Healium Clinical’s Expansion into Healthcare Settings Nationwide
OncoSil Medical secures TGA approval for pancreatic cancer device
The approval is expected to drive increased clinical adoption and support applications for regulatory approval in other markets.
Early warning from low-risk cysts could help catch pancreatic cancer sooner
In a new study, Mass General Brigham investigators showed that patients with low-risk pancreatic cystic lesions (PCLs) have approximately 14 times higher risk of developing pancreatic cancer than the general population.
Discovery shows how cancer takes hold as cells divide
University of Virginia School of Medicine scientists have revealed how mistakes in the final step of cell division can have dire consequences for developing brain cells.
New technique discovers previously unknown population of immune cells in the Alzheimer’s brain
Researchers have discovered a previously unknown population of immune cells in the brains of Alzheimer’s patients that is found almost exclusively in the vicinity of a specific type of pathological protein deposit.
Common food preservatives linked to high blood pressure and heart disease
The research was led by Dr. Mathilde Touvier, a research director at INSERM (the French National Institute for Health and Medical Research), and Anaïs Hasenböhler, Ph.D. student, both from the Nutritional Epidemiology Research Team at the Université Sorbonne Paris Nord and Université Paris Cité, France.
Leo Cancer Care Secures CE Mark for Marie®, Advancing Upright Radiotherapy in Europe
Leo Cancer Care’s CE mark approval for Marie® signals a transformative shift in how radiotherapy is delivered across Europe.